Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
In the prescription medication industry, there are single glucagon-like peptide-1 (GLP-1) receptor agonist options (weight loss injections) and dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist options that are marketed for the treatment of diabetes, obesity, and weight management solutions
While most patients tolerate GLP-1 injections well, common side effects like nausea, vomiting, diarrhea, and constipation tend to improve over time
Bridgewater: Sanofi-Aventis US LLC
The management strategies are largely the same across the class
In significant enough amounts, GLP-1 also triggers a feeling of fullness in the brain
